MiRNAs as Legitimate Targets for Cancer Therapy

被引：0
作者：
Wang, Zhiwei [1 ]
机构：
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
来源：
CURRENT DRUG TARGETS | 2013年 / 14卷 / 10期
关键词：
D O I：
10.2174/1389450111314100001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1093 / 1093
页数：1
相关论文
共 50 条
  • [31] Circulating miRNAs in cancer: from detection to therapy
    Wen-Tao Wang
    Yue-Qin Chen
    Journal of Hematology & Oncology, 7
  • [32] miRNAs as Modulators of EGFR Therapy in Colorectal Cancer
    Pereira, Diane M.
    Rodrigues, Cecilia M. P.
    TARGETED THERAPY OF COLORECTAL CANCER SUBTYPES, 2018, 1110 : 133 - 147
  • [33] Circulating miRNAs in cancer: from detection to therapy
    Wang, Wen-Tao
    Chen, Yue-Qin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2014, 7
  • [34] Novel Targets in Cancer Therapy
    Banerjee, Debabrata
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2009, 10 (02) : 147 - 147
  • [35] Molecular targets in cancer therapy
    Kummar, Shivaani
    Doroshow, James H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (03) : 267 - 269
  • [36] Targets for Therapy of Bladder Cancer
    Seidl, Christof
    SEMINARS IN NUCLEAR MEDICINE, 2020, 50 (02) : 162 - 170
  • [37] Mitochondria as targets for cancer therapy
    Ralph, Stephen J.
    Neuzil, Jiri
    MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 (01) : 9 - 28
  • [38] Metabolic targets for cancer therapy
    Galluzzi, Lorenzo
    Kepp, Oliver
    Vander Heiden, Matthew G.
    Kroemer, Guido
    NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (11) : 829 - 846
  • [39] Lysosornes as targets for cancer therapy
    Fehrenbacher, N
    Jäättelä, M
    CANCER RESEARCH, 2005, 65 (08) : 2993 - 2995
  • [40] Sphingolipid targets in cancer therapy
    Modrak, DE
    Gold, DV
    Goldenberg, DM
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (02) : 200 - 208
12345